Thrombopoietin signaling to chromatin elicits rapid and pervasive epigenome remodeling within poised chromatin architectures
Year: 2018
Type: preprint
Abstract: Thrombopoietin (TPO) is a critical cytokine regulating hematopoietic stem cell maintenance and differentiation into the megakaryocytic lineage. However, the transcriptional and chromatin dynamics elicited by TPO signaling are poorly understood. Here, we study the immediate early transcriptional and cis -regulatory responses to TPO in hematopoietic stem/progenitor cells (HSPCs) and use this paradigm of cytokine signaling to chromatin to dissect the relationship between cis -regulatory activity and chromatin architecture. We show that TPO profoundly alters the transcriptome of HSPCs, with key hematopoietic regulators being transcriptionally repressed within 30 min of TPO. By examining cis -regulatory dynamics and chromatin architectures, we demonstrate that these changes are accompanied by rapid and extensive epigenome remodeling of cis -regulatory landscapes that is spatially coordinated within topologically associating domains (TADs). Moreover, TPO-responsive enhancers are spatially clustered and engage in preferential homotypic intra- and inter-TAD interactions that are largely refractory to TPO signaling. By further examining the link between cis -regulatory dynamics and chromatin looping, we show that rapid modulation of cis -regulatory activity is largely independent of chromatin looping dynamics. Finally, we show that, although activated and repressed cis -regulatory elements share remarkably similar DNA sequence compositions, transcription factor binding patterns accurately predict rapid cis -regulatory responses to TPO.
Source: Genome Research
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
Estimated APC paid: $5,292
Funders: Leukemia and Lymphoma Society, Wellcome Trust, Cancer Research UK, National Institute for Health and Care Research, Kay Kendall Leukaemia Fund, European Commission, Bloodwise, Blood Cancer UK, Directorate for Biological Sciences, Medical Research Council, Biotechnology and Biological Sciences Research Council
Awards: To study epigenetic mechanisms regulating lineage commitment and cell potency, G2401687207, G2537149883, G2992180400, G34383514, Supporting transnational mobility within the European life sciences by cofunding of the EMBO Fellowship Programme, G5707549070, G7567962354, CALR mutations and human myeloproliferative neoplasms.
OpenAlex ID: W2952829451
